全文获取类型
收费全文 | 2984篇 |
免费 | 477篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 69篇 |
妇产科学 | 157篇 |
基础医学 | 307篇 |
口腔科学 | 52篇 |
临床医学 | 847篇 |
内科学 | 619篇 |
皮肤病学 | 27篇 |
神经病学 | 212篇 |
特种医学 | 128篇 |
外科学 | 431篇 |
综合类 | 23篇 |
一般理论 | 2篇 |
预防医学 | 149篇 |
眼科学 | 10篇 |
药学 | 128篇 |
中国医学 | 6篇 |
肿瘤学 | 303篇 |
出版年
2023年 | 14篇 |
2022年 | 31篇 |
2021年 | 62篇 |
2020年 | 24篇 |
2019年 | 48篇 |
2018年 | 94篇 |
2017年 | 125篇 |
2016年 | 139篇 |
2015年 | 140篇 |
2014年 | 141篇 |
2013年 | 192篇 |
2012年 | 153篇 |
2011年 | 178篇 |
2010年 | 127篇 |
2009年 | 135篇 |
2008年 | 156篇 |
2007年 | 152篇 |
2006年 | 144篇 |
2005年 | 133篇 |
2004年 | 134篇 |
2003年 | 104篇 |
2002年 | 76篇 |
2001年 | 74篇 |
2000年 | 76篇 |
1999年 | 63篇 |
1998年 | 29篇 |
1997年 | 33篇 |
1996年 | 44篇 |
1995年 | 29篇 |
1994年 | 25篇 |
1993年 | 25篇 |
1992年 | 66篇 |
1991年 | 61篇 |
1990年 | 47篇 |
1989年 | 42篇 |
1988年 | 44篇 |
1987年 | 38篇 |
1986年 | 34篇 |
1985年 | 36篇 |
1984年 | 23篇 |
1983年 | 20篇 |
1982年 | 23篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 21篇 |
1978年 | 13篇 |
1976年 | 13篇 |
1972年 | 12篇 |
1971年 | 13篇 |
1970年 | 14篇 |
排序方式: 共有3483条查询结果,搜索用时 443 毫秒
81.
82.
83.
84.
85.
86.
87.
88.
89.
Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease 总被引:5,自引:0,他引:5
Lo Bianco C Schneider BL Bauer M Sajadi A Brice A Iwatsubo T Aebischer P 《Proceedings of the National Academy of Sciences of the United States of America》2004,101(50):17510-17515
Parkinson's disease (PD) is characterized by a progressive loss of midbrain dopamine neurons and the presence of cytoplasmic inclusions called Lewy bodies. Mutations in several genes including alpha-synuclein and parkin have been linked to familial PD. The loss of parkin's E3-ligase activity leads to dopaminergic neuronal degeneration in early-onset autosomal recessive juvenile parkinsonism, suggesting a key role of parkin for dopamine neuron survival. To evaluate the potential neuroprotective role of parkin in the pathogenesis of PD, we tested whether overexpression of wild-type rat parkin could protect against the toxicity of mutated human A30P alpha-synuclein in a rat lentiviral model of PD. Animals overexpressing parkin showed significant reductions in alpha-synuclein-induced neuropathology, including preservation of tyrosine hydroxylase-positive cell bodies in the substantia nigra and sparing of tyrosine hydroxylase-positive nerve terminals in the striatum. The parkin-mediated neuroprotection was associated with an increase in hyperphosphorylated alpha-synuclein inclusions, suggesting a key role for parkin in the genesis of Lewy bodies. These results indicate that parkin gene therapy may represent a promising candidate treatment for PD. 相似文献
90.
Arnhold IJ Oliveira SB Osorio MG Carrilho AJ Nicolau W Bianco AC Mendonca BB 《Journal of endocrinological investigation》2000,23(4):258-262
Two patients with growth hormone (GH) gene deletions were treated with recombinant insulin-like growth factor-I (IGF-I) (80-240 (microg/kg/day) and the effects on bone mass and body composition were compared to administration of GH (0.075 U/kg/day) to 8 patients with idiopathic GH deficiency. Bone mass and body composition were measured by dual photon X-ray absorptiometry (DEXA ) before and 3 and 6 months after treatment with GH or IGF-I. Similar increases in growth velocities were observed after GH and IGF-I treatment. Treatment with GH resulted in prompt and significant reduction in body fat percentage (basal, 3 and 6 months: 22+/-10, 17+/-9, and 16+/-9%) whereas body fat percentage remained unchanged after IGF-I therapy (basal, 3 and 6 months: 49, 52 and 48% in patient 1 and 45, 42 and 43% in patient 2, respectively). Fat percentage remained elevated after 18 months of IGF-I treatment in patients 1 (51%) and 2 (44%), respectively. Lean mass and bone mineral content increased with GH and IGF-I therapies. We conclude that reduction of body fat measured by DEXA, observed after administration of GH but not after IGF-I treatment in these children with GH deficiency, suggests that the GH effect on body fat mass is not mediated by circulating IGF-I. 相似文献